Trade Summary

3 months ago, Deep Track Biotechnology Master Fund, Ltd., serving as 10% owner at Lb Pharmaceuticals Inc (LBRX), purchased 2,666,666 shares at $15.00 per share, for a total transaction value of $39,999,990.00. Following this transaction, Deep Track Biotechnology Master Fund, Ltd. now holds 3,352,804 shares of LBRX.

This purchase represents a 389.00% increase in Deep Track Biotechnology Master Fund, Ltd.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, September 12, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, September 16, 2025, 4 days after the trade was made.

Lb Pharmaceuticals Inc operates in the NONE sector, specifically within the NONE industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.